In large clinical trials, a full dose anticoagulation (blood thinner) treatment given to moderately ill patients hospitalized for COVID-19 reduced the requirement of vital organ support, such as the need for mechanical ventilation.
A trend in possible reduction of mortality was also observed and is being further studied.
Read More
